Intensity Modulated Radiation Therapy for Prostate Cancer

NCT00214422 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
19
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Cancer Institute (NCI)